You searched for Antibody candidate - Page 45 of 69

Morphogen IX pulmonary arterial hypertension

More News! 20 Dec 2018

Cambridge Company Raises €20M for Potential First in Lung Disease

…until its acquisition in 2017, had a big phase III failure with a drug candidate for the same condition. The lead candidate of Morphogen-IX is a protein, called bone morphogenetic…

December 20, 2018 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 28 Jul 2020

Record Series A for Italian Biotech Funds Autoimmune Therapy

Italian biotech Enthera raised €28M in Series A funding to develop its drug candidate for type 1 diabetes and inflammatory bowel disease and take it to human trials. Enthera was…

July 28, 2020 - 3 minutesmins - By Helen Albert

balmes transplantation kidney disorders 1

News and Trends 22 May 2020

Phase II Fail Ends Swiss-US Drug for Rare Kidney Disease

…Swiss collaborator Vifor Pharma to drop it for this indication. Topline results from the phase II trial showed that 12 weeks of treatment with the drug candidate did not decrease…

May 22, 2020 - 2 minutesmins - By Anita Chakraverty

Best in Biotech 12 Jun 2023

Six advancements in Alzheimer’s research over the past year

…have advanced as well. For the treatment of Alzheimer’s, lecanemab, a monoclonal antibody that targets amyloid plaques, was developed by Japanese pharmaceutical Eisai in collaboration with American biopharma Biogen. It…

June 12, 2023 - 12 minutesmins - By Roohi Mariam Peter

News and Trends 3 Jan 2018

What Are Clinical Trials and Why Do We Do Them?

…new drug will be tested in humans, giving us the chance to find out exactly how it interacts with the body and whether it is any good. The candidate will…

January 3, 2018 - 6 minutesmins - By Alex Dale

News and Trends 6 Jan 2023

BioNTech partnering with UK Government on personalized mRNA cancer immunotherapies

…UK as one of the company’s key markets. As part of the MoU, BioNTech and the UK Government plan to accelerate trial site and patient recruitment for clinical candidates of…

January 6, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 11 Aug 2022

Synlogic gets Ginkgo Bioworks’ help to launch T. rex inspired synthetic biotic for gout

Synlogic, Inc. has announced a new drug candidate for the treatment of gout developed in partnership with Ginkgo Bioworks. The new candidate, SYNB2081, is a synthetic biotic and is the…

August 11, 2022 - 2 minutesmins - By Jim Cornall

Best in Biotech 10 Oct 2024

12 biotech unicorns revolutionizing the future of healthcare

…understanding to inform future discovery. Part of Xaira’s team includes researchers who developed models for protein and antibody design called RFdiffusion and RFantibody in Baker’s lab. The company will use…

October 10, 2024 - 11 minutesmins - By Willow Shah-Neville

News and Trends 3 Jun 2020

What Did European Oncology Players Offer at ASCO 2020?

…blood cancer and solid tumors. The candidate that Autolus presented, called AUTO3, is designed to hit two targets at once and make it harder for blood cancer to relapse than…

June 3, 2020 - 10 minutesmins - By Jonathan Smith

Best in Biotech 9 Jul 2024

The 7 biotech companies in Portugal you should know about in 2024

…amyloidosis. This disease is caused by a mutation that leads the protein transthyretin to build up, causing progressive degeneration of multiple organs and tissues. BSIM’s most advanced drug candidate, currently…

July 9, 2024 - 7 minutesmins - By Willow Shah-Neville

Expert Advice 5 Apr 2024

How to build a career as an investigator at the FDA?

…degree, a candidate must have 4 years of comparable experience To qualify for a Band B position, a candidate must have: A bachelor’s degree and 3 years of comparable experience…

April 5, 2024 - 7 minutesmins - By Jules Adam

News and Trends 25 Mar 2021

Covid-19 Vaccine Approvals Bring Hope and Challenges for Adenoviral Technology

…to adenoviral treatments. Earlier this month, Johnson & Johnson’s candidate became the first single-shot Covid-19 vaccine to get the EMA green light. The vaccine is based on a genetically modified…

March 25, 2021 - 6 minutesmins - By Victor Kotsev

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Cambridge Company Raises €20M for Potential First in Lung Disease

Record Series A for Italian Biotech Funds Autoimmune Therapy

Phase II Fail Ends Swiss-US Drug for Rare Kidney Disease

Six advancements in Alzheimer’s research over the past year

What Are Clinical Trials and Why Do We Do Them?

BioNTech partnering with UK Government on personalized mRNA cancer immunotherapies

Synlogic gets Ginkgo Bioworks’ help to launch T. rex inspired synthetic biotic for gout

12 biotech unicorns revolutionizing the future of healthcare

What Did European Oncology Players Offer at ASCO 2020?

The 7 biotech companies in Portugal you should know about in 2024

How to build a career as an investigator at the FDA?

Covid-19 Vaccine Approvals Bring Hope and Challenges for Adenoviral Technology

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!